Supplemental Equity and Comprehensive Income (Loss) Information - Narrative (Details) - $ / shares	3 Months Ended												12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Common stock, par value (in dollars per share)	$ 0.01				$ 0.01				$ 0.01				$ 0.01	$ 0.01	$ 0.01
Common stock, authorized (in shares)	3,000,000,000				3,000,000,000				3,000,000,000				3,000,000,000	3,000,000,000	3,000,000,000
Common stock, issued (in shares)	944,033,056				944,033,056				944,033,056				944,033,056	944,033,056	944,033,056
Preferred stock, authorized (in shares)	10,000,000				10,000,000				10,000,000				10,000,000	10,000,000	10,000,000
Dividends declared in period (in dollars per share)	$ 1.50	$ 1.50	$ 1.50	$ 1.50	$ 1.49	$ 1.49	$ 1.49	$ 1.49	$ 1.48	$ 1.48	$ 1.48	$ 1.48	$ 6.00	$ 5.96	$ 5.92